M.L. Bernal
Impact in
- Genetics top 10%
- Mesenchymal stem cell research
- Genetic Associations and Epidemiology
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Carcinogens and Genotoxicity Assessment 5
-
- Effects and risks of endocrine disrupting chemicals 3
- Toxic Organic Pollutants Impact 2
- Co-authors
- B. Sinués (7 shared papers)E Mayayo (2 shared papers)M.A. Sáenz (6 shared papers)Francisco José Vázquez (1 shared paper)C. Rodellar (1 shared paper)Jaber Lyahyai (1 shared paper)P. Zaragoza (1 shared paper)B. Ranera (1 shared paper)
In The Last Decade
M.L. Bernal
21 papers receiving 647 citations
Peers
Comparison fields: 5 of 90
- Genetics 117
- Pharmacology 76
- Nephrology 54
- Cancer Research 84
- Urology 28
Countries citing papers authored by M.L. Bernal
This map shows the geographic impact of M.L. Bernal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Bernal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Bernal more than expected).
Fields of papers citing papers by M.L. Bernal
This network shows the impact of papers produced by M.L. Bernal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Bernal. The network helps show where M.L. Bernal may publish in the future.
Co-authors
The 25 scholars most cited alongside M.L. Bernal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 162 | |
| 2 | 2011 | 137 | |
| 3 | 2003 | 68 | |
| 4 | 1995 | 58 | |
| 5 | 2007 | 57 | |
| 6 | Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow. | 1999 | 30 |
| 7 | 1991 | 26 | |
| 8 | 1991 | 20 | |
| 9 | Urinary mutagenicity and N-acetylation phenotype in textile industry workers exposed to arylamines. | 1992 | 18 |
| 10 | Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain. | 2000 | 17 |
| 11 | 1995 | 14 | |
| 12 | 2016 | 11 | |
| 13 | Lethal faciocardiomelic dysplasia- a new autosomal recessive disorder. | 1975 | 10 |
| 14 | 2021 | 10 | |
| 15 | 2018 | 7 | |
| 16 | 2025 | 5 | |
| 17 | 1994 | 4 | |
| 18 | 2005 | 3 | |
| 19 | [Hydronephrosis and urinary retention secondary to extrinsic compression by an ovarian cyst in a girl]. | 1992 | 2 |
| 20 | 2006 | 2 |
About M.L. Bernal
M.L. Bernal is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine, Rheumatology and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 663 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (5 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Genomic variations and chromosomal abnormalities (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Toxic Organic Pollutants Impact (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Tuberous Sclerosis Complex Research (1 paper). The work is most often cited by research in Genetics (117 citations), Pharmacology (76 citations), Nephrology (54 citations), Cancer Research (84 citations) and Urology (28 citations). M.L. Bernal has collaborated with scholars based in Spain, Italy and China. Frequent co-authors include B. Sinués, E Mayayo, M.A. Sáenz, Francisco José Vázquez, C. Rodellar, Jaber Lyahyai, P. Zaragoza, B. Ranera, Inmaculada Martín‐Burriel and Antonio Romero Lasheras. Their work appears in journals such as Journal of Toxicology and Environmental Health, Journal of the American Heart Association, BioMed Research International, Clinical Pharmacology & Therapeutics and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.